Literature DB >> 35015083

Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial.

Marta Garaulet1,2,3, Jesus Lopez-Minguez1,2, Hassan S Dashti4,5,6, Céline Vetter5,7, Antonio Miguel Hernández-Martínez8, Millán Pérez-Ayala9, Juan Carlos Baraza1,2, Wei Wang3,10, Jose C Florez4,5,11, Frank A J L Scheer3,5,10, Richa Saxena4,5,6.   

Abstract

OBJECTIVE: We tested whether the concurrence of food intake and elevated concentrations of endogenous melatonin, as occurs with late eating, results in impaired glucose control, in particular in carriers of the type 2 diabetes-associated G allele in the melatonin receptor-1B gene (MTNR1B). RESEARCH DESIGN AND METHODS: In a Spanish natural late-eating population, a randomized, crossover study was performed. Each participant (n = 845) underwent two evening 2-h 75-g oral glucose tolerance tests following an 8-h fast: an early condition scheduled 4 h prior to habitual bedtime ("early dinner timing") and a late condition scheduled 1 h prior to habitual bedtime ("late dinner timing"), simulating an early and a late dinner timing, respectively. Differences in postprandial glucose and insulin responses between early and late dinner timing were determined using incremental area under the curve (AUC) calculated by the trapezoidal method.
RESULTS: Melatonin serum levels were 3.5-fold higher in the late versus early condition, with late dinner timing resulting in 6.7% lower insulin AUC and 8.3% higher glucose AUC. The effect of late eating impairing glucose tolerance was stronger in the MTNR1B G-allele carriers than in noncarriers. Genotype differences in glucose tolerance were attributed to reductions in β-cell function (P for interaction, Pint glucose area under the curve = 0.009, Pint corrected insulin response = 0.022, and Pint disposition index = 0.018).
CONCLUSIONS: Concurrently high endogenous melatonin and carbohydrate intake, as typical for late eating, impairs glucose tolerance, especially in MTNR1B G-risk allele carriers, attributable to insulin secretion defects.
© 2022 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35015083      PMCID: PMC8918262          DOI: 10.2337/dc21-1314

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  37 in total

1.  Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.

Authors:  R L Hanson; R E Pratley; C Bogardus; K M Narayan; J M Roumain; G Imperatore; A Fagot-Campagna; D J Pettitt; P H Bennett; W C Knowler
Journal:  Am J Epidemiol       Date:  2000-01-15       Impact factor: 4.897

2.  Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women.

Authors:  A Cagnacci; S Arangino; A Renzi; A M Paoletti; G B Melis; P Cagnacci; A Volpe
Journal:  Clin Endocrinol (Oxf)       Date:  2001-03       Impact factor: 3.478

3.  Melatonin signalling and type 2 diabetes risk: too little, too much or just right?

Authors:  Hindrik Mulder
Journal:  Diabetologia       Date:  2017-03-16       Impact factor: 10.122

4.  Late dinner impairs glucose tolerance in MTNR1B risk allele carriers: A randomized, cross-over study.

Authors:  Jesus Lopez-Minguez; Richa Saxena; Cristina Bandín; Frank A Scheer; Marta Garaulet
Journal:  Clin Nutr       Date:  2017-04-10       Impact factor: 7.324

Review 5.  Melatonin, endocrine pancreas and diabetes.

Authors:  Elmar Peschke
Journal:  J Pineal Res       Date:  2008-01       Impact factor: 13.007

6.  Differential effects of the circadian system and circadian misalignment on insulin sensitivity and insulin secretion in humans.

Authors:  Jingyi Qian; Chiara Dalla Man; Christopher J Morris; Claudio Cobelli; Frank A J L Scheer
Journal:  Diabetes Obes Metab       Date:  2018-07-02       Impact factor: 6.577

7.  Type 2 diabetes-associated variants of the MT2 melatonin receptor affect distinct modes of signaling.

Authors:  Angeliki Karamitri; Bianca Plouffe; Amélie Bonnefond; Min Chen; Jonathan Gallion; Jean-Luc Guillaume; Alan Hegron; Mathilde Boissel; Mickaël Canouil; Claudia Langenberg; Nicholas J Wareham; Christian Le Gouill; Viktoria Lukasheva; Olivier Lichtarge; Philippe Froguel; Michel Bouvier; Ralf Jockers
Journal:  Sci Signal       Date:  2018-08-28       Impact factor: 8.192

Review 8.  Melatonin in type 2 diabetes mellitus and obesity.

Authors:  Angeliki Karamitri; Ralf Jockers
Journal:  Nat Rev Endocrinol       Date:  2019-02       Impact factor: 43.330

9.  TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH).

Authors:  Shylaja Srinivasan; Varinderpal Kaur; Bindu Chamarthi; Katherine R Littleton; Ling Chen; Alisa K Manning; Jordi Merino; Melissa K Thomas; Margo Hudson; Allison Goldfine; Jose C Florez
Journal:  Diabetes Care       Date:  2018-01-11       Impact factor: 19.112

10.  Daytime eating prevents internal circadian misalignment and glucose intolerance in night work.

Authors:  Sarah L Chellappa; Jingyi Qian; Nina Vujovic; Christopher J Morris; Arlet Nedeltcheva; Hoa Nguyen; Nishath Rahman; Su Wei Heng; Lauren Kelly; Kayla Kerlin-Monteiro; Suhina Srivastav; Wei Wang; Daniel Aeschbach; Charles A Czeisler; Steven A Shea; Gail K Adler; Marta Garaulet; Frank A J L Scheer
Journal:  Sci Adv       Date:  2021-12-03       Impact factor: 14.136

View more
  3 in total

Review 1.  Genetics of circadian rhythms and sleep in human health and disease.

Authors:  Jacqueline M Lane; Jingyi Qian; Emmanuel Mignot; Susan Redline; Frank A J L Scheer; Richa Saxena
Journal:  Nat Rev Genet       Date:  2022-08-26       Impact factor: 59.581

Review 2.  A matter of time: A systematic scoping review on a potential role of the circadian system in binge eating behavior.

Authors:  Francisco Romo-Nava; Anna I Guerdjikova; Nicole N Mori; Frank A J L Scheer; Helen J Burgess; Robert K McNamara; Jeffrey A Welge; Carlos M Grilo; Susan L McElroy
Journal:  Front Nutr       Date:  2022-09-08

Review 3.  Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements.

Authors:  Deanna M Minich; Melanie Henning; Catherine Darley; Mona Fahoum; Corey B Schuler; James Frame
Journal:  Nutrients       Date:  2022-09-22       Impact factor: 6.706

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.